<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
  <meta http-equiv="Content-Style-Type" content="text/css" />
  <meta name="generator" content="pandoc" />
  <title></title>
  <style type="text/css">code{white-space: pre;}</style>
</head>
<body>
<h3 id="mondo0007950"><a href="http://purl.obolibrary.org/obo/MONDO_0007950">MONDO:0007950</a></h3>
<p><strong>Label:</strong> mastocytosis</p>
<p><strong>Subclasses:</strong> <a href="http://purl.obolibrary.org/obo/MONDO_0019315">MONDO:0019315</a> (diffuse cutaneous mastocytosis), <a href="http://purl.obolibrary.org/obo/MONDO_0019316">MONDO:0019316</a> (Maculopapular cutaneous mastocytosis), <a href="http://purl.obolibrary.org/obo/MONDO_0016586">MONDO:0016586</a> (systemic mastocytosis), <a href="http://purl.obolibrary.org/obo/MONDO_0019023">MONDO:0019023</a> (cutaneous mastocytosis), <a href="http://purl.obolibrary.org/obo/MONDO_0020331">MONDO:0020331</a> (indolent systemic mastocytosis), <a href="http://purl.obolibrary.org/obo/MONDO_0020333">MONDO:0020333</a> (aggressive systemic mastocytosis), <a href="http://purl.obolibrary.org/obo/MONDO_0020334">MONDO:0020334</a> (mast cell leukemia),</p>
<p><strong>Corr. equiv. classes:</strong> <a href="http://www.orpha.net/ORDO/Orphanet_2467">Orphanet:2467</a>, <a href="http://www.orpha.net/ORDO/Orphanet_79457">Orphanet:79457</a>, <a href="http://purl.obolibrary.org/obo/OMIM_154800">OMIM:154800</a>, <a href="http://www.orpha.net/ORDO/Orphanet_66646">Orphanet:66646</a>, <a href="http://www.orpha.net/ORDO/Orphanet_98848">Orphanet:98848</a>, <a href="http://www.orpha.net/ORDO/Orphanet_98850">Orphanet:98850</a>, <a href="http://www.orpha.net/ORDO/Orphanet_98851">Orphanet:98851</a>, <a href="http://www.orpha.net/ORDO/Orphanet_79456">Orphanet:79456</a>,</p>
<p><strong>Class expressions from DL-Learner:</strong></p>
<ul>
<li><a href="http://purl.obolibrary.org/obo/HP_0005547">HP:0005547</a> (Myeloproliferative disorder) and <a href="http://purl.obolibrary.org/obo/HP_0100852">HP:0100852</a> (Abnormal fear/anxiety-related behavior) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0005547">HP:0005547</a> (Myeloproliferative disorder) and <a href="http://purl.obolibrary.org/obo/HP_0100495">HP:0100495</a> (Mastocytosis) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0005547">HP:0005547</a> (Myeloproliferative disorder) and <a href="http://purl.obolibrary.org/obo/HP_0100494">HP:0100494</a> (Abnormal mast cell morphology) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0005547">HP:0005547</a> (Myeloproliferative disorder) and <a href="http://purl.obolibrary.org/obo/HP_0031466">HP:0031466</a> (Impairment in personality functioning) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0005547">HP:0005547</a> (Myeloproliferative disorder) and <a href="http://purl.obolibrary.org/obo/HP_0030956">HP:0030956</a> (Abnormality of cardiovascular system electrophysiology) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0005547">HP:0005547</a> (Myeloproliferative disorder) and <a href="http://purl.obolibrary.org/obo/HP_0012638">HP:0012638</a> (Abnormality of nervous system physiology) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0005547">HP:0005547</a> (Myeloproliferative disorder) and <a href="http://purl.obolibrary.org/obo/HP_0012531">HP:0012531</a> (Pain) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0005547">HP:0005547</a> (Myeloproliferative disorder) and <a href="http://purl.obolibrary.org/obo/HP_0011849">HP:0011849</a> (Abnormal bone ossification) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0005547">HP:0005547</a> (Myeloproliferative disorder) and <a href="http://purl.obolibrary.org/obo/HP_0011843">HP:0011843</a> (Abnormality of skeletal physiology) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0005547">HP:0005547</a> (Myeloproliferative disorder) and <a href="http://purl.obolibrary.org/obo/HP_0011842">HP:0011842</a> (Abnormality of skeletal morphology) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0005547">HP:0005547</a> (Myeloproliferative disorder) and <a href="http://purl.obolibrary.org/obo/HP_0011675">HP:0011675</a> (Arrhythmia) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0005547">HP:0005547</a> (Myeloproliferative disorder) and <a href="http://purl.obolibrary.org/obo/HP_0011122">HP:0011122</a> (Abnormality of skin physiology) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0005547">HP:0005547</a> (Myeloproliferative disorder) and <a href="http://purl.obolibrary.org/obo/HP_0011024">HP:0011024</a> (Abnormality of the gastrointestinal tract) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0005547">HP:0005547</a> (Myeloproliferative disorder) and <a href="http://purl.obolibrary.org/obo/HP_0011001">HP:0011001</a> (Increased bone mineral density) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0004349">HP:0004349</a> (Reduced bone mineral density) and <a href="http://purl.obolibrary.org/obo/HP_0005547">HP:0005547</a> (Myeloproliferative disorder) 62.50%</li>
</ul>
</body>
</html>
